| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4529147
Max Phase: Preclinical
Molecular Formula: C21H25N5
Molecular Weight: 347.47
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Nc1ccc(CN2CCC(n3cc(Cc4ccccc4)nn3)CC2)cc1
Standard InChI: InChI=1S/C21H25N5/c22-19-8-6-18(7-9-19)15-25-12-10-21(11-13-25)26-16-20(23-24-26)14-17-4-2-1-3-5-17/h1-9,16,21H,10-15,22H2
Standard InChI Key: PXLJRBKDJVSTTQ-UHFFFAOYSA-N
Associated Targets(Human)
Bcl-xL/Bcl-2-binding component 3 27 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 347.47 | Molecular Weight (Monoisotopic): 347.2110 | AlogP: 3.29 | #Rotatable Bonds: 5 |
| Polar Surface Area: 59.97 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.70 | CX LogP: 2.91 | CX LogD: 1.59 |
| Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -1.33 |
References
| 1. Ramana Murthy AV, Narendar V, Kumar NS, Aparna P, Durga Bhavani AK, Gautier F, Barillé-Nion S, Juin P, Mosset P, Grée R, Levoin N.. (2019) Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cells., 162 [PMID:30453244] [10.1016/j.ejmech.2018.10.069] |
Source
Source(1):